Preclinical Results Highlight Competitive Potential Preclinical data released by SureNano Science suggest that GEP-44 may offer meaningful differentiation compared with earlier-generation GLP therapies, positioning the company for meaningful upside as it progresses through its development phases of the FDA approval pathway
Serious adverse events remain uncommon in non-diabetic populations using semaglutide for weight loss alone, though individual medical histories, concomitant medications, and baseline health conditions always require provider evaluation
Ozempic GLIP-1RA Vision Loss Lawsuit Information Center News Updates for GLP-1 RA Ozempic Lawsuits How Much Compensation Can You Get in an Ozempic Settlement for NAION Vision Impairment
Potential Benefits of BPC-157 Based on preclinical data, BPC-157 is being studied for multiple therapeutic applications
I convert my prescribed dose in milligrams to milliliters by dividing the dose by the concentration
Make sure your hormones are optimized in our office we see additional weight loss gains with utilization of testosterone replacement in both men and women, with up to an additional 10-20% weight loss respectively and patients better able to maintain their weight loss results